Defective K-Ras oncoproteins overcome impaired effector activation to initiate leukemia in vivo.

Shieh A, Ward AF, Donlan KL, Harding-Theobald ER, Xu J, Mullighan CG, Zhang C, Chen SC, Su X, Downing JR, Bollag GE, Shannon KM